ECO Animal Health Group (LON:EAH) Shares Down 15.5%

ECO Animal Health Group plc (LON:EAH - Get Free Report)'s stock price was down 15.5% during mid-day trading on Tuesday . The company traded as low as GBX 70 ($0.94) and last traded at GBX 82 ($1.10). Approximately 136,248 shares traded hands during trading, an increase of 23% from the average daily volume of 110,393 shares. The stock had previously closed at GBX 97 ($1.30).

Analysts Set New Price Targets

Separately, Shore Capital reaffirmed a "buy" rating on shares of ECO Animal Health Group in a research note on Tuesday, August 27th.

ECO Animal Health Group Stock Down 23.7 %

The company has a debt-to-equity ratio of 4.31, a current ratio of 2.96 and a quick ratio of 2.14. The firm has a market cap of £50.13 million, a PE ratio of 4,100.00 and a beta of -0.05. The business has a fifty day moving average price of GBX 106.31 and a two-hundred day moving average price of GBX 109.56.

Insiders Place Their Bets

In other ECO Animal Health Group news, insider David Hallas acquired 18,181 shares of the business's stock in a transaction that occurred on Friday, August 30th. The stock was acquired at an average price of GBX 110 ($1.47) per share, with a total value of £19,999.10 ($26,751.07). Insiders own 20.97% of the company's stock.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.